Lux Health Tech Acquisition Corp.

Lux Health Tech Acquisition Corp. (Nasdaq: LUXA) is a blank check company formed to pursue a business combination in the health technology sector. Sponsored by an affiliate of Lux Capital, a venture capital firm with a long-standing focus on science and technology investments, LUXA completed its initial public offering in 2021. The company filed a definitive proxy statement (DEF 14A) with the SEC on September 20, 2022, accession number 0001564590-22-032009, indicating that shareholders were being asked to vote on a proposed business combination at that stage. Lux Capital's deep network in digital health and life sciences informed the deal-sourcing strategy behind the vehicle. For complete filing history, transaction details, and real-time status updates on LUXA, sign up for full data access at SpacDesk.